Different risk of acute feto-fetal transfusion in basic clinical subtypes of monochorionic twins
Hašlík Lubomír1, Gratacós Eduard2, Petra Hanulíková3
1Institute for the Care of Mother and Child, Podolské nábřeží 157, 147 00, Prague, Czech Republic; 3rd Medical Faculty, Charles University, Ruska 2411/87, 100 00, Prague, Czech Republic.
Abstract:
Analysis of the potential risk of acute feto-fetal transfusion (aFFT) in different clinical types of monochorionic twins using an in vitro placental simulation model. The prospective study analyzed 157 fresh MC placentas from 2014 to 2020, excluding those with intrauterine intervention. A specially designed protocol was used for their preparation and analysis. The study included 108 placentas with an uncomplicated course, 31 cases of selective fetal growth restriction (sFGR), and 18 cases of twin-to-twin transfusion syndrome (TTTS). The number and types of anastomoses, umbilical cord insertion distances (UCID), and placental areas for each fetus were statistically analyzed. The primary objective was to assess differences in aFFT among various MC twin subtypes. The secondary objectives were to identify risk factors associated with the development of aFFT. 76/157 (48.4 %) cases of aFFT were confirmed, with an average transfusion time of 1 mL in 50 s (8-240 s). The occurrence of aFFT in uncomplicated, sFGR, and TTTS placentas was 62,5 %, 50,9 %, and 5,9 %, respectively (p < 0.001). The representation of AA anastomoses was significantly higher in the sFGR and uncomplicated groups compared to TTTS (84.4 % and 80.6 % vs. 11.8 %; p < 0.001). Besides the presence of AA anastomosis, the main independent risk factor for the development of aFFT is its diameter (p < 0.001). The potential risk of aFFT differs significantly among individual clinical subtypes of MC twins, depending on the presence and size of AA anastomosis.
More Related Videos
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Teratogenicity
Rh Blood Group
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...


